Skip to main content
Erschienen in:

03.08.2020 | Reports of Original Investigations

Carbetocin compared with oxytocin in non-elective Cesarean delivery: a systematic review, meta-analysis, and trial sequential analysis of randomized-controlled trials

verfasst von: Desire N. Onwochei, MBBS, Adetokunbo Owolabi, MBBS, Preet Mohinder Singh, MD, David T. Monks, MBChB

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Carbetocin has been shown to reduce the requirement for additional uterotonics in women exclusively undergoing elective Cesarean delivery (CD). The aim of this review was to determine whether this effect could also be demonstrated in the setting of non-elective CD.

Methods

Medline, Embase, CINAHL, Web of Science and Cochrane databases were searched for randomized-controlled trials (RCTs) in any language comparing carbetocin to oxytocin. Studies with data on women undergoing non-elective CD, where carbetocin was compared with oxytocin, were included. The primary outcome was the need for additional uterotonics. Secondary outcomes included incidence of blood transfusion, estimated blood loss (mL), incidence of postpartum hemorrhage (PPH; > 1000 mL) and mean hemoglobin drop (g·dL−1

Results

Five RCTs were included, with a total of 1,214 patients. The need for additional uterotonics was reduced with carbetocin compared with oxytocin (odds ratio, 0.30; 95% CI, 0.11 to 0.86; I2, 90.60%). Trial sequential analysis (TSA) confirmed that the information size needed to show a significant reduction in the need for additional uterotonics had been exceeded. No significant differences were shown with respect to any of the secondary outcomes, but there was significant heterogeneity between the studies.

Conclusions

Carbetocin reduces the need for additional uterotonics in non-elective CD compared with oxytocin. TSA confirmed that this analysis was appropriately powered to detect the pooled estimated effect. Further trials utilizing consistent core outcomes are needed to determine an effect on PPH.

Trial registration

PROSPERO CRD42019147256, registered 13 September 2019.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014; 2: 323-33.CrossRef Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014; 2: 323-33.CrossRef
2.
Zurück zum Zitat Anderson JM, Etches D. Prevention and management of postpartum hemorrhage. Am Fam Physician 2007; 75: 875-82.PubMed Anderson JM, Etches D. Prevention and management of postpartum hemorrhage. Am Fam Physician 2007; 75: 875-82.PubMed
4.
Zurück zum Zitat Mousa H, Blum J, El Senoun A, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage (Review). Cochrane Database Syst Rev 2014; 2: CD003249. Mousa H, Blum J, El Senoun A, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage (Review). Cochrane Database Syst Rev 2014; 2: CD003249.
5.
Zurück zum Zitat Heesen M, Carvalho B, Carvalho JC, et al. International consensus statement on the use of uterotonic agents during caesarean section. Anaesthesia 2019; 74: 1305-19.CrossRef Heesen M, Carvalho B, Carvalho JC, et al. International consensus statement on the use of uterotonic agents during caesarean section. Anaesthesia 2019; 74: 1305-19.CrossRef
6.
Zurück zum Zitat Hunter DJ, Schulz P, Wassenaar W. Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther 1992; 52: 60-7.CrossRef Hunter DJ, Schulz P, Wassenaar W. Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther 1992; 52: 60-7.CrossRef
9.
Zurück zum Zitat Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol 2004; 104: 1005-10.CrossRef Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol 2004; 104: 1005-10.CrossRef
10.
Zurück zum Zitat Balki M, Ronayne M, Davies S, et al. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol 2006; 107: 45-50.CrossRef Balki M, Ronayne M, Davies S, et al. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol 2006; 107: 45-50.CrossRef
11.
Zurück zum Zitat Khan M, Balki M, Ahmed I, et al. Carbetocin at elective cesarean delivery: a sequential allocation trial to determine the minimum effective dose. Can J Anesth 2014; 61: 242-8.CrossRef Khan M, Balki M, Ahmed I, et al. Carbetocin at elective cesarean delivery: a sequential allocation trial to determine the minimum effective dose. Can J Anesth 2014; 61: 242-8.CrossRef
12.
Zurück zum Zitat Nguyen-Lu N, Carvalho JC, Farine D, Seaward G, Ye XY, Balki M. Carbetocin at cesarean delivery for labour arrest: a sequential allocation trial to determine the effective dose. Can J Anesth 2015; 62: 866-74.CrossRef Nguyen-Lu N, Carvalho JC, Farine D, Seaward G, Ye XY, Balki M. Carbetocin at cesarean delivery for labour arrest: a sequential allocation trial to determine the effective dose. Can J Anesth 2015; 62: 866-74.CrossRef
13.
Zurück zum Zitat Onwochei DN, Van Ross J, Singh P, Salter A, Monks DT. Carbetocin reduces the need for additional uterotonics in elective caesarean delivery: a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials. Int J Obstet Anesth 2019; 40: 14-23.CrossRef Onwochei DN, Van Ross J, Singh P, Salter A, Monks DT. Carbetocin reduces the need for additional uterotonics in elective caesarean delivery: a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials. Int J Obstet Anesth 2019; 40: 14-23.CrossRef
16.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. J Clin Epidemiol 2009; 62: 1006-12. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. J Clin Epidemiol 2009; 62: 1006-12.
18.
Zurück zum Zitat Thiessen Philbrook H, Barrowman N, Garg AX. Imputing variance estimates do not alter the conclusions of a meta-analysis with continuous outcomes: a case study of changes in renal function after living kidney donation. J Clin Epidemiol 2007; 60: 228-40.CrossRef Thiessen Philbrook H, Barrowman N, Garg AX. Imputing variance estimates do not alter the conclusions of a meta-analysis with continuous outcomes: a case study of changes in renal function after living kidney donation. J Clin Epidemiol 2007; 60: 228-40.CrossRef
19.
Zurück zum Zitat Chowdhry AK, Dworkin RH, McDermott MP. Meta-analysis with missing study-level sample variance data. Stat Med 2016; 35: 3021-32.CrossRef Chowdhry AK, Dworkin RH, McDermott MP. Meta-analysis with missing study-level sample variance data. Stat Med 2016; 35: 3021-32.CrossRef
21.
Zurück zum Zitat Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6.CrossRef Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6.CrossRef
22.
Zurück zum Zitat Attilakos G, Psaroudakis D, Ash J, et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG 2010; 117: 929-36.CrossRef Attilakos G, Psaroudakis D, Ash J, et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG 2010; 117: 929-36.CrossRef
23.
Zurück zum Zitat El Behery MM, El Sayed GA, El Hameed AA, Soliman BS, Abdelsalam WA, Bahaa A. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in obese nulliparous women undergoing emergency cesarean delivery. J Matern Fetal Neonatal Med 2016; 29: 1257-60.CrossRef El Behery MM, El Sayed GA, El Hameed AA, Soliman BS, Abdelsalam WA, Bahaa A. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in obese nulliparous women undergoing emergency cesarean delivery. J Matern Fetal Neonatal Med 2016; 29: 1257-60.CrossRef
24.
Zurück zum Zitat Razali N, Latar IL, Chan YK, Omar SZ, Tan PC. Carbetocin compared to oxytocin in emergency cesarean section: a randomized trial. Eur J Obstet Gynecol Reprod Biol 2016; 198: 35-9.CrossRef Razali N, Latar IL, Chan YK, Omar SZ, Tan PC. Carbetocin compared to oxytocin in emergency cesarean section: a randomized trial. Eur J Obstet Gynecol Reprod Biol 2016; 198: 35-9.CrossRef
25.
Zurück zum Zitat Taheripanah R, Shoman A, Karimzadeh MA, Zamaniyan M, Malih N. Efficacy of oxytocin versus carbetocin in prevention of postpartum hemorrhage after cesarean section under general anesthesia: a prospective randomized clinical trial. J Matern Fetal Neonatal Med 2018; 31: 2807-12.CrossRef Taheripanah R, Shoman A, Karimzadeh MA, Zamaniyan M, Malih N. Efficacy of oxytocin versus carbetocin in prevention of postpartum hemorrhage after cesarean section under general anesthesia: a prospective randomized clinical trial. J Matern Fetal Neonatal Med 2018; 31: 2807-12.CrossRef
26.
Zurück zum Zitat Whigham CA, Gorelik A, Loughnan TE, Trivedi A. Carbetocin versus oxytocin to reduce additional uterotonic use at non-elective caesarean section: a double-blind, randomised trial. J Fetal Matern Neonatal Med 2016; 29: 3866-9.CrossRef Whigham CA, Gorelik A, Loughnan TE, Trivedi A. Carbetocin versus oxytocin to reduce additional uterotonic use at non-elective caesarean section: a double-blind, randomised trial. J Fetal Matern Neonatal Med 2016; 29: 3866-9.CrossRef
28.
Zurück zum Zitat Jin B, Du Y, Zhang F, Zhang K, Wang L, Cui L. Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med 2016; 29: 400-7.CrossRef Jin B, Du Y, Zhang F, Zhang K, Wang L, Cui L. Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med 2016; 29: 400-7.CrossRef
29.
Zurück zum Zitat Monks DT, Palanisamy A. Intrapartum oxytocin: time to focus on longer term consequences? Anaesthesia 2019; 74: 1219-22.CrossRef Monks DT, Palanisamy A. Intrapartum oxytocin: time to focus on longer term consequences? Anaesthesia 2019; 74: 1219-22.CrossRef
Metadaten
Titel
Carbetocin compared with oxytocin in non-elective Cesarean delivery: a systematic review, meta-analysis, and trial sequential analysis of randomized-controlled trials
verfasst von
Desire N. Onwochei, MBBS
Adetokunbo Owolabi, MBBS
Preet Mohinder Singh, MD
David T. Monks, MBChB
Publikationsdatum
03.08.2020
Verlag
Springer International Publishing
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 11/2020
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-020-01779-1

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Neu im Fachgebiet AINS

Nasenstimulation lindert chronische Migräne

Wird die Naseninnenseite durch Vibrationen stimuliert, kann dies offenbar die Zahl der Migränetage von Menschen mit chronischer Migräne deutlich senken. Darauf deuten die Resultate einer randomisiert-kontrollierten deutsch-finnischen Untersuchung.

Nackenschmerzen nach Bandscheibenvorfall: Muskeltraining hilft!

Bei hartnäckigen Schmerzen aufgrund einer zervikalen Radikulopathie schlägt ein Team der Universität Istanbul vor, lokale Steroidinjektionen mit einem speziellen Trainingsprogramm zur Stabilisierung der Nackenmuskulatur zu kombinieren.

Okzipitale Nervenstimulation: Op.-Erfahrungen aus Dänemark

Derzeit gibt es kein breit akzeptiertes Standardprotokoll, was das chirurgische Vorgehen bei okzipitaler Nervenstimulation betrifft. Ein Ärzteteam aus Dänemark hat nun seinen Ansatz vorgestellt, der bestimmte Vorteile bieten soll.

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.